Pain relief has a long history that dates back more than 5000 years. However, it was only in recent years that we acquired adequate levels of knowledge concerning pathophysiology, nociception and the mechanism of action of analgesic substances.
Irrespective of its origin, pain, especially when chronic, is a potentially invalidating condition that can compromise the quality of life of individuals, preventing them from getting around, working and leading an active life.
In the whole of Europe, approximately 500 million work days are lost each year due to chronic and acute pain, with an enormous social and economic impact.
Of the various remedies available for symptomatic pain treatment, nonsteroidal anti-inflammatory drugs (NSAIDs) have been commonly used for some time, and are indicated in a vast variety of conditions, such as muscle, tendon and joint injuries, backache, menstrual pain, toothache and headache.
IBSA has placed on the global market innovative formulations, such as drug-in-adhesive medicated patches using hydrogel technology, that afford optimum absorption and rapid relief of pain caused by soft tissue injuries, musculoskeletal disorders and other clinical conditions characterised by acute and chronic pain.
